[Therapy of cardiac insufficiency with digitalis glycosides].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000652:urine; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000628:therapy; D008107:Liver Diseases / Q000378:metabolism; D011802:Quinidine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D004077:Digoxin; D004074:Digitoxin; D011802:Quinidine
Therapie der Herzinsuffizienz mit Digitalis.